Home > Newsletters > FDAnews Drug Daily Bulletin > Mexico Taking Closer Look at Clinical Trial Protocols, Investigator Sites
FDAnews Drug Daily Bulletin
Oct. 19, 2012 | Vol. 9 No. 206
Mexico Taking Closer Look at Clinical Trial Protocols, Investigator Sites
Mexico’s drug regulator Cofepris has doubled its clinical trial protocol review timeline, with approvals coming in six months now instead of three, an expert says. The addition of three months comes as the number of foreign clinical trials has begun to boom in Mexico, with more trials being conducted at smaller clinical sites, Rosalinda Mondragon, investigational product manager at Sanofi-Aventis Mexico, told IPRM.
International Pharmaceutical Regulatory Monitor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.